Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Curiel

Showing results (41-50 of 400) with videos related to

Pageof 40
Sort By:
Advanced Drug Delivery Reviews|May 9, 2009
Advancements in adenoviral based virotherapy for ovarian cancerKellie S Matthews, Ronald D Alvarez, David T Curiel
Drug Discovery Today|March 30, 2021
The era of gene therapy: From preclinical development to clinical applicationNabil A Alhakamy, David T Curiel, Cory J Berkland
NPJ Vaccines|August 6, 2021
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemicSamir Andrade Mendonça, Reka Lorincz, Paul Boucher, et al.
Virus Research|August 25, 2004
Fiber-mosaic adenovirus as a novel approach to design genetically modified adenoviral vectorsLarisa Pereboeva, Svetlana Komarova, Parameshwar J Mahasreshti, et al.
Cancer Biology & Therapy|January 8, 2009
PI3K: A rational target for ovarian cancer therapy?Paul Dent, Steven Grant, Paul B Fisher, et al.
Cancer Science|August 20, 2009
Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancerAmy R Nelson, Julia Davydova, David T Curiel, et al.
Oncogene|November 22, 2005
Oncolytic adenoviruses - selective retargeting to tumor cellsJ Michael Mathis, Mariam A Stoff-Khalili, David T Curiel
Cancer Biology & Therapy|December 17, 2009
Minting a new class of polo-like-kinase inhibitorsPaul Dent, David T Curiel, Steven Grant, et al.
Advances in Cancer Research|June 5, 2026
AAV vectors for cancer gene therapyMyungeun Lee, Jinhyun Park, Ji Hoon Park, et al.
Molecular Pharmaceutics|October 26, 2018
Capsid-Incorporation Strategy To Display Antigens for an Alternative Adenoviral Vector Vaccine ApproachClaudia A J van Winkel, Alberto Moreno, David T Curiel
Pageof 40

Showing results (41-50 of 400) with videos related to

Sort By:
Pageof 40
Advanced Drug Delivery Reviews|May 9, 2009
Advancements in adenoviral based virotherapy for ovarian cancerKellie S Matthews, Ronald D Alvarez, David T Curiel
Drug Discovery Today|March 30, 2021
The era of gene therapy: From preclinical development to clinical applicationNabil A Alhakamy, David T Curiel, Cory J Berkland
NPJ Vaccines|August 6, 2021
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemicSamir Andrade Mendonça, Reka Lorincz, Paul Boucher, et al.
Virus Research|August 25, 2004
Fiber-mosaic adenovirus as a novel approach to design genetically modified adenoviral vectorsLarisa Pereboeva, Svetlana Komarova, Parameshwar J Mahasreshti, et al.
Cancer Biology & Therapy|January 8, 2009
PI3K: A rational target for ovarian cancer therapy?Paul Dent, Steven Grant, Paul B Fisher, et al.
Cancer Science|August 20, 2009
Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancerAmy R Nelson, Julia Davydova, David T Curiel, et al.
Oncogene|November 22, 2005
Oncolytic adenoviruses - selective retargeting to tumor cellsJ Michael Mathis, Mariam A Stoff-Khalili, David T Curiel
Cancer Biology & Therapy|December 17, 2009
Minting a new class of polo-like-kinase inhibitorsPaul Dent, David T Curiel, Steven Grant, et al.
Advances in Cancer Research|June 5, 2026
AAV vectors for cancer gene therapyMyungeun Lee, Jinhyun Park, Ji Hoon Park, et al.
Molecular Pharmaceutics|October 26, 2018
Capsid-Incorporation Strategy To Display Antigens for an Alternative Adenoviral Vector Vaccine ApproachClaudia A J van Winkel, Alberto Moreno, David T Curiel
Pageof 40